Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Researcher Patricia Martens turned dry data into stories.

Silversides A.

Healthc Policy. 2015 Feb;10(3):10-3. No abstract available.

2.

Complications of stomas: their aetiology and management.

Watson AJ, Nicol L, Donaldson S, Fraser C, Silversides A.

Br J Community Nurs. 2013 Mar;18(3):111-2, 114, 116.

PMID:
23653957
3.

Blogging the nursing life.

Silversides A.

Can Nurse. 2012 Jan;108(1):22-7. No abstract available.

PMID:
22372097
4.

Use of strong opioids in Canada rose sharply between 2005 and 2010.

Silversides A.

BMJ. 2011 Aug 25;343:d5441. doi: 10.1136/bmj.d5441. No abstract available.

PMID:
21868459
5.

When loss leads in new directions. Jane Simington shares hard-won lessons about healing.

Silversides A.

Can Nurse. 2011 Jun;107(6):34-5. No abstract available.

PMID:
21761805
6.

Inquest jury seeks to take prescription opioids off Ontario's streets.

Silversides A.

BMJ. 2011 Jul 11;343:d4371. doi: 10.1136/bmj.d4371. No abstract available.

PMID:
21745797
7.

Withdrawal of clinical trials policy by Canadian research institute is a "lost opportunity for increased transparency".

Silversides A.

BMJ. 2011 Apr 21;342:d2570. doi: 10.1136/bmj.d2570. No abstract available.

PMID:
21511787
8.

A young career in high gear.

Silversides A.

Can Nurse. 2011 Mar;107(3):32-3. No abstract available.

PMID:
21469412
9.

Journal clubs: a forum for discussion and professional development.

Silversides A.

Can Nurse. 2011 Feb;107(2):18-23. No abstract available.

PMID:
21462630
10.

Australia moves to combat the misuse of prescription opioids.

Silversides A.

BMJ. 2011 Feb 28;342:d1345. doi: 10.1136/bmj.d1345. No abstract available.

PMID:
21357354
11.

Tight regulation of French drug reps mean French doctors get more balanced information than doctors in the US.

Silversides A.

BMJ. 2010 Dec 3;341:c6964. doi: 10.1136/bmj.c6964. No abstract available.

PMID:
21131344
12.

Canadian physicians playing "catch-up" in adopting electronic medical records.

Silversides A.

CMAJ. 2010 Feb 9;182(2):E103-4. doi: 10.1503/cmaj.109-3126. Epub 2009 Dec 7. No abstract available.

13.

Inuit health system must move past suicide prevention to "unlock a better reality," conference told.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E46. doi: 10.1503/cmaj.109-3117. Epub 2009 Nov 30. No abstract available.

14.

Improved Aboriginal child health data collection urged.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E47. doi: 10.1503/cmaj.109-3119. Epub 2009 Nov 30. No abstract available.

15.

Scientists have a duty to challenge government policies, top researcher says.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E35-6. doi: 10.1503/cmaj.109-3114. Epub 2009 Nov 23. No abstract available.

16.

"Chaos" protects health privacy.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E37-8. doi: 10.1503/cmaj.109-3115. Epub 2009 Nov 23. No abstract available.

17.

Federal committee to review appointment of Pfizer vice-president to CIHR governing council.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E33-4. doi: 10.1503/cmaj.109-3113. Epub 2009 Nov 19. No abstract available.

18.

Social scientists redirected to CIHR for grants.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E27-8. doi: 10.1503/cmaj.109-3110. Epub 2009 Nov 16. No abstract available.

19.

Drug companies should target drug plans, rather than physicians, consultant says.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E21-2. doi: 10.1503/cmaj.109-3101. Epub 2009 Nov 9. No abstract available.

20.

Drug safety provisions in US and Europe outshine Canada.

Silversides A.

CMAJ. 2010 Jan 12;182(1):E23-4. doi: 10.1503/cmaj.109-3102. Epub 2009 Nov 9. No abstract available.

21.

Cost of HPV vaccine is prohibitive in developing world, Nobel winner says.

Silversides A.

CMAJ. 2009 Dec 8;181(12):E288. doi: 10.1503/cmaj.109-3094. Epub 2009 Nov 2. No abstract available.

22.

Privacy concerns raised over "secondary use" of health records.

Silversides A.

CMAJ. 2009 Dec 8;181(12):E287. doi: 10.1503/cmaj.109-3089. Epub 2009 Oct 26. No abstract available.

23.

Appointment of Pfizer executive to CIHR stirs controversy.

Silversides A.

CMAJ. 2009 Nov 24;181(11):E256-7. doi: 10.1503/cmaj.109-3085. Epub 2009 Oct 26. No abstract available.

24.

Governments make inroads into medical self-regulation.

Silversides A.

CMAJ. 2009 Nov 24;181(11):784-5. doi: 10.1503/cmaj.109-3081. Epub 2009 Oct 19. No abstract available.

25.

Clinical trial for Fabry disease faces continuing hurdles.

Silversides A.

CMAJ. 2009 Nov 24;181(11):E251-2. doi: 10.1503/cmaj.109-3071. Epub 2009 Oct 13. No abstract available.

26.

Stem cell hype risks "backlash".

Silversides A.

CMAJ. 2009 Nov 24;181(11):E246. doi: 10.1503/cmaj.109-3074. Epub 2009 Oct 13. No abstract available.

27.

Outcome of health-related legal challenges is sometimes surprising.

Silversides A.

CMAJ. 2009 Nov 24;181(11):E247-8. doi: 10.1503/cmaj.109-3075. Epub 2009 Oct 13. No abstract available.

28.

Australia's flying doctors tackle Third World health issues.

Silversides A.

CMAJ. 2009 Nov 10;181(10):E229-31. doi: 10.1503/cmaj.109-3037. Epub 2009 Sep 28. No abstract available.

29.

Tales from the C. difficile trenches.

Silversides A.

CMAJ. 2009 Oct 27;181(9):E197-8. doi: 10.1503/cmaj.109-3057. Epub 2009 Sep 28. No abstract available.

30.

Public reports of infection rates urged.

Silversides A.

CMAJ. 2009 Oct 27;181(9):573-4. doi: 10.1503/cmaj.109-3056. Epub 2009 Sep 21. No abstract available.

31.

Regulatory colleges to set painkiller guidelines.

Silversides A.

CMAJ. 2009 Oct 13;181(8):464-5. doi: 10.1503/cmaj.109-3031. Epub 2009 Sep 21. No abstract available. Erratum in: CMAJ. 2009 Nov 24;181(11):827.

32.

Ontario takes aim at painkiller abuse.

Silversides A.

CMAJ. 2009 Oct 13;181(8):E141-2. doi: 10.1503/cmaj.109-3032. Epub 2009 Sep 21. No abstract available.

33.

Opioid prescribing challenges doctors.

Silversides A.

CMAJ. 2009 Oct 13;181(8):E143-4. doi: 10.1503/cmaj.109-3033. Epub 2009 Sep 21. No abstract available. Erratum in: CMAJ. 2009 Nov 10;181(10):716.

34.

Survey reveals health impact of downturn.

Silversides A.

CMAJ. 2009 Oct 13;181(8):E153-4. doi: 10.1503/cmaj.109-3020. Epub 2009 Sep 21. No abstract available.

35.

Physician mobility remains a "moving target".

Silversides A.

CMAJ. 2009 Oct 27;181(9):E191-2. doi: 10.1503/cmaj.109-3050. Epub 2009 Sep 21. No abstract available.

36.

Fabry trial set to answer "political problem".

Silversides A.

CMAJ. 2009 Sep 15;181(6-7):365-6. doi: 10.1503/cmaj.109-3015. No abstract available.

37.

Enzyme therapy for Fabry patients in jeopardy.

Silversides A.

CMAJ. 2009 Sep 15;181(6-7):E120. doi: 10.1503/cmaj.109-3013. No abstract available.

38.

Provincial experiments aim to lower public drug plan costs.

Silversides A.

CMAJ. 2009 Sep 1;181(5):E80-2. doi: 10.1503/cmaj.091257. No abstract available.

39.

Postmarket drug surveillance network to be overseen by Canadian Institutes of Health Research.

Silversides A.

CMAJ. 2009 Aug 4;181(3-4):E51. doi: 10.1503/cmaj.091126. No abstract available.

40.

Ontario's law curbing the cost of generic drugs sparks changes for pharmacies and other Canadian buyers.

Silversides A.

CMAJ. 2009 Aug 4;181(3-4):E43-5. doi: 10.1503/cmaj.091155. No abstract available. Erratum in: CMAJ. 2009 Oct 27;181(9):617.

41.

Charter challenge of ban on direct-to-consumer advertising to be heard by Ontario court in mid-June.

Silversides A.

CMAJ. 2009 Jul 7;181(1-2):E5-6. doi: 10.1503/cmaj.091050. No abstract available.

42.

Cord blood bank plans evolve with "glacial speed".

Silversides A.

CMAJ. 2009 Jun 23;180(13):1295-6. doi: 10.1503/cmaj.090971. No abstract available.

43.

Canada's genetic heterogeneity an asset in cord blood banking.

Silversides A.

CMAJ. 2009 Jun 23;180(13):E117. doi: 10.1503/cmaj.090989. No abstract available.

44.

Quebec left with numerous vacancies after resident match.

Silversides A.

CMAJ. 2009 Jun 23;180(13):E115-6. doi: 10.1503/cmaj.090977. No abstract available.

45.

Canada's ability to respond to a national health crisis hampered by jurisdictional issues, untested emergency plans.

Silversides A.

CMAJ. 2009 Jun 9;180(12):1193-4. doi: 10.1503/cmaj.090870. No abstract available.

46.

Swine flu outbreak tests Canadian preparedness.

Silversides A.

CMAJ. 2009 Jun 9;180(12):E93-4. doi: 10.1503/cmaj.090805. No abstract available.

47.

Long road to Sprinkles.

Silversides A.

CMAJ. 2009 May 26;180(11):1098. doi: 10.1503/cmaj.090787. No abstract available.

48.

Push to link medical research innovations to public good.

Silversides A.

CMAJ. 2009 May 26;180(11):1097-8. doi: 10.1503/cmaj.090788. No abstract available. Erratum in: CMAJ. 2009 Jun 23;180(13):1331.

49.

World must respond to threat of drug-resistant tuberculosis.

Silversides A.

CMAJ. 2009 May 12;180(10):E37. doi: 10.1503/cmaj.090695. No abstract available.

50.

Clinical trial participation poses ethical, practical issues.

Silversides A.

CMAJ. 2009 Mar 3;180(5):500-2. doi: 10.1503/cmaj.090131. No abstract available.

Supplemental Content

Loading ...
Support Center